Company Description
AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China.
The company operates through four segments: Products, Pharmacies, Hotel, and Manufacture and Sales. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, foods, and drinks; and rhino king, colostrum powder derived from goat’s milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules.
The company provides products purchased from third parties, as well as advertising and marketing services.
It sells its products through its pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing, as well, as an omni-channel business.
The company is based in Chengdu, China.
Country | United States |
Founded | 1987 |
Industry | Food Distribution |
Sector | Consumer Staples |
Employees | 207 |
CEO | Quanzhong Lin |
Contact Details
Address: Hongxing Intl Business Building 2, 14th Flr, No. 69, Qingyun Souve Ave., Jinjiang District,chengdu City, F4 610021 China | |
Phone | 212-739-7689 |
Website | aixinjituan.com |
Stock Details
Ticker Symbol | AIXN |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000835662 |
CUSIP Number | 009603200 |
ISIN Number | US0096033099 |
Employer ID | 84-1085935 |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Quanzhong Lin | Secretary, President, Chief Executive Officer and Chairman |
Tianfeng Li | Chief Financial Officer and Treasurer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 13, 2024 | 10-Q | Quarterly Report |
May 16, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
Apr 8, 2024 | 10-K | Annual Report |
Apr 2, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Feb 9, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Nov 14, 2023 | 10-Q | Quarterly Report |
Aug 18, 2023 | 10-Q | Quarterly Report |
Aug 15, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
Jul 25, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jun 26, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |